Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) closed the day trading at $12.3 up 1.23% from the previous closing price of $12.15. In other words, the price has increased by $1.23 from its previous closing price. On the day, 0.78 million shares were traded. CRBP stock price reached its highest trading level at $12.51 during the session, while it also had its lowest trading level at $11.7.
Ratios:
For a better understanding of CRBP, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.21 and its Current Ratio is at 9.21. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 24 ’25 when Cohen Yuval sold 18,660 shares for $17.01 per share. The transaction valued at 317,407 led to the insider holds 138,187 shares of the business.
Cohen Yuval sold 8,973 shares of CRBP for $153,797 on Oct 27 ’25. The Chief Executive Officer now owns 138,187 shares after completing the transaction at $17.14 per share. On Oct 24 ’25, another insider, Moran Sean F., who serves as the Chief Financial Officer of the company, sold 12,981 shares for $17.02 each. As a result, the insider received 220,937 and left with 73,313 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRBP now has a Market Capitalization of 209093312 and an Enterprise Value of 36603268.
Stock Price History:
The Beta on a monthly basis for CRBP is 2.70, which has changed by -0.36553526 over the last 52 weeks, in comparison to a change of 0.18286073 over the same period for the S&P500. Over the past 52 weeks, CRBP has reached a high of $20.77, while it has fallen to a 52-week low of $4.64. The 50-Day Moving Average of the stock is -6.82%, while the 200-Day Moving Average is calculated to be 32.95%.
Shares Statistics:
Over the past 3-months, CRBP traded about 252.88K shares per day on average, while over the past 10 days, CRBP traded about 744560 shares per day. A total of 12.25M shares are outstanding, with a floating share count of 10.80M. Insiders hold about 11.84% of the company’s shares, while institutions hold 65.02% stake in the company. Shares short for CRBP as of 1760486400 were 986251 with a Short Ratio of 3.90, compared to 1757894400 on 1196113. Therefore, it implies a Short% of Shares Outstanding of 986251 and a Short% of Float of 10.0200005.
Earnings Estimates
The market rating of Corbus Pharmaceuticals Holdings Inc (CRBP) is currently shaped by the ongoing analysis conducted by 10.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$1.57, with high estimates of -$0.71 and low estimates of -$3.57.
Analysts are recommending an EPS of between -$4.95 and -$12.56 for the fiscal current year, implying an average EPS of -$6.42. EPS for the following year is -$5.34, with 9.0 analysts recommending between -$2.79 and -$7.02.
